

An emerging biopharma company focused on advanced therapies for rare diseases and niche oncology partnered with IQVIA to characterize patients and HCPs in an environment of high data scarcity. IQVIA utilized its proprietary solutions to create a unified dataset, and applied machine learning to identify key patient and HCP segments. This innovative approach led to an assessment of over 1600 patient profiles and more than 300 HCPs, and a 61% increase in account coverage, effectively addressing the data scarcity challenge and driving business growth. Also, the research led to a scientific publication that allowed the company to share novel insights with the medical community. Read the case study to learn more about IQVIA's innovative data triangulation approach.